AKE 0.00% $9.83 allkem limited

Ann: September quarterly activities report, page-64

  1. 19,544 Posts.
    lightbulb Created with Sketch. 271
    Livent has more to lose if this merger does not proceed.

    imo Allkem should have a greater ratio of the new merged company. The shorts could be twofold, one Livent reports a poor result, shorts will pile in further and two the merger “may” fail, shorts get their pay day.
 
watchlist Created with Sketch. Add AKE (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.